Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial

BACKGROUND: The objectives of this study were to determine the objective effective response rate, survival, and safety of radiotherapy combined with gefitinib in patients with locally advanced non-small cell lung cancer (NSCLC) who were unfit for surgery or concurrent chemoradiotherapy. METHODS: The...

Full description

Saved in:
Bibliographic Details
Published in:Radiat Oncol
Main Authors: Fu, Zhixue, Yang, Xu, Wang, Wenqing, Deng, Lei, Zhang, Tao, Bi, Nan, Wang, Xiaozhen, Chen, Dongfu, Zhou, Zongmei, Wang, Luhua, Liang, Jun
Format: Artigo
Language:Inglês
Published: BioMed Central 2020
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7305585/
https://ncbi.nlm.nih.gov/pubmed/32563259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-020-01596-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items